3 Monster Dividend Stocks to Hold for the Next 10 Years

The article recommends three dividend stocks for long-term 10-year investors: Clorox (strengthened by its Purell acquisition and offering a 5% yield), Brown-Forman (with 42 consecutive years of dividend increases and a 3.6% yield despite current market softness), and Kimberly-Clark (undergoing major transformation with trusted brands and 50+ years of dividend growth). All three are positioned as overlooked opportunities for patient investors seeking steady compounding returns.

06/21/2026, 3:05 AM • The Motley Fool

Where to Put $1,000 When the Market Is This Uncertain

In an uncertain market marked by tariff-driven inflation and low consumer sentiment, the article recommends three consumer staples companies as stable investments for a $1,000 allocation: Church & Dwight for its volume-driven growth, Keurig Dr Pepper for its high-growth energy drink portfolio, and Kenvue for its strong beauty and health brands ahead of its merger with Kimberly-Clark.

06/20/2026, 4:05 AM • The Motley Fool

[Latest] Surgical Masks Market Size Will Attain USD 6.76 Billion by 2034 Registering a Promising CAGR of 5.5% - Exclusive Report by ZMR | Global Surgical Masks Market Size, Share, Trends Analysis Report

The global surgical masks market is projected to grow from USD 3.95 billion in 2024 to USD 6.76 billion by 2034 at a CAGR of 5.5%. Growth is driven by rising healthcare applications, infection control awareness, and surgical interventions, though environmental concerns about disposal and competition from alternative respirators pose challenges. Europe is expected to lead the market, while basic surgical masks will dominate the product segment.

06/08/2026, 7:00 AM • GlobeNewswire

Kimberly-Clark vs. The Clorox: Which Consumer Goods Stock Is a Better Buy in 2026?

The article compares Kimberly-Clark and Clorox as investment options for 2026. Both companies face challenges including high debt loads, customer concentration risk (Walmart accounts for 16-27% of sales), and intense competition. Kimberly-Clark is undergoing significant restructuring with a potential $48 billion merger with Kenvue and selling its international tissue business, while Clorox is recovering from a 2023 cyberattack and pandemic-era slowdown. The author recommends Clorox as the safer choice due to its stronger brand positioning, though acknowledges Kimberly-Clark offers higher upside potential despite greater integration risks.

05/28/2026, 4:17 PM • The Motley Fool

Kimberly-Clark Declares Quarterly Dividend

Kimberly-Clark Corporation has declared a regular quarterly dividend of $1.28 per share, payable on July 2, 2026. The company has maintained dividend payments for 92 consecutive years and increased its dividend for 54 consecutive years, demonstrating strong financial stability and commitment to shareholders.

05/14/2026, 4:15 PM • Benzinga

These Market Signals Alarm Me, but I Still See Profit Potential in These 3 Consumer Stocks

Despite concerning market valuation signals like the Shiller P/E ratio at 41 and record cash holdings at Berkshire Hathaway, the author identifies three consumer dividend stocks with strong fundamentals: Realty Income (99% occupancy, 5.1% yield), Clorox (temporary headwinds but decades of dividend increases, 5.6% yield), and Kimberly-Clark (upcoming Kenvue merger, 54-year dividend streak, 5.2% yield). All three trade at attractive valuations relative to the broader market.

05/09/2026, 7:11 AM • The Motley Fool

CJ Biomaterials and Yuhan-Kimberly Launch World’s First Reusable Nonwoven Paper Towel Made with Amorphous PHA

CJ Biomaterials and Yuhan-Kimberly have launched the Kleenex® Biodegradable Reusable Dishtowel, the world's first reusable nonwoven paper towel made with amorphous PHA technology. The 100% biobased product combines cellulose with CJ's proprietary PHACT™ A1000P material derived from sugarcane and is certified for home and commercial compostability without producing persistent microplastics. The product is now available in South Korea.

05/07/2026, 9:00 AM • GlobeNewswire

These 3 Dividend Stocks Have Made Investors Rich. They Can Do It Again.

Three consumer goods dividend stocks are positioned for growth: Hershey benefits from a 74% drop in cocoa prices enabling margin expansion; General Mills offers a 7% yield amid transformation and cost structure improvements; Kimberly-Clark is acquiring Kenvue to create a scaled personal-care platform with strong brands and long-term dividend durability.

05/07/2026, 8:15 AM • The Motley Fool

The Best Dividend Stock to Own During a Market Crash

Kimberly-Clark is recommended as a defensive dividend stock for potential market downturns due to its essential consumer staples products, 54-year dividend increase streak, and attractive 5.2% yield. Despite a 30% stock price decline from its June high due to the $48.7 billion Kenvue acquisition financing concerns, the stock's low P/E ratio of 15 and strong free cash flow support suggest limited downside risk.

05/05/2026, 2:30 PM • The Motley Fool

Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%

Hedge fund billionaire Daniel Loeb reduced his stake in Kenvue Inc. by 64% in Q4 2025, cutting holdings from 9.0 million to 3.25 million shares. The consumer health company, which includes brands like Tylenol and Listerine, is undergoing a restructuring that will reduce workforce by 3.5% with $250 million in charges expected in 2026. Kenvue's acquisition by Kimberly-Clark at $48.7 billion enterprise value is expected to close in H2 2026 pending regulatory approval.

04/24/2026, 2:19 PM • Benzinga

From Kleenex to Fish Fingers: A 5-Pack of Staples Stocks Yielding up to 11%

The article examines five consumer staples stocks offering high dividend yields (up to 11%) despite sector challenges. While staples traditionally provide defensive value, recent inflation concerns and private-label competition have pressured these stocks. The five highlighted companies—Kimberly-Clark, Nomad Foods, Conagra Brands, Cal-Maine Foods, and Flowers Foods—offer attractive yields but face headwinds including input cost inflation, GLP-1 adoption impacts, and earnings pressures that could threaten dividend sustainability.

04/24/2026, 11:32 AM • Investing

The Smartest Dividend Stocks to Buy With $2,000 Right Now

The article recommends three dividend stocks for investors seeking income: PepsiCo, which is showing signs of recovery after underperformance; Kenvue, a spinoff from Johnson & Johnson offering reliable recurring income with an upcoming merger; and Procter & Gamble, a consumer staples giant with 70 consecutive years of dividend increases.

04/19/2026, 4:05 PM • The Motley Fool

Looking for a High-Yield Alternative to Costco Wholesale and Walmart? Consider This Dirt Cheap Dividend King Stock.

While Costco and Walmart have delivered strong returns, their valuations are stretched with forward P/E ratios of 48.7 and 43.4 respectively, and low dividend yields of 0.5% and 0.8%. Kimberly-Clark offers a compelling alternative with a 5.3% dividend yield, 54 consecutive years of dividend increases, and a cheap valuation at 12.8x forward earnings. The company's strategic exit from low-margin private-label diapers and planned acquisition of Kenvue (adding brands like Band-Aid and Tylenol) position it for margin expansion and dividend growth.

04/15/2026, 1:15 PM • The Motley Fool

The 3 Highest-Yielding Dividend Kings in April

Three Dividend Kings—Altria, Universal Corporation, and Kimberly-Clark—currently offer the highest dividend yields among elite dividend stocks that have increased dividends for 50+ consecutive years. Altria yields 6.3% but faces declining cigarette demand in North America. Universal yields 6.1% as a global tobacco supplier with stronger international demand. Kimberly-Clark yields 5.2% and is pursuing a growth strategy through its acquisition of Kenvue, though this carries integration risks. All three are considered riskier investments suitable primarily for aggressive investors.

04/12/2026, 10:15 AM • The Motley Fool

Could Buying This Dividend Pharma Stock Today Set You Up for Life?

Johnson & Johnson is highlighted as an exceptional dividend stock for retirees, boasting a 63-year dividend-increase streak as a Dividend King. The diversified healthcare company combines pharmaceutical and medical device businesses, with an AAA credit rating ensuring dividend stability. However, its 2.2% yield, while double the S&P 500's 1.1%, falls short of the 4% target many dividend investors seek.

04/09/2026, 8:15 PM • The Motley Fool